In summary, human metastatic colorectal cancer, which had survived previous systemic chemotherapy, was sensitive to T-cell-mediated killing as shown using the novel CEA-specific BiTE MEDI-565. Here, CEACAM5 is linked to metastatic colorectal cancer.